Sweden · Series A startup

Who invested in Asgard Therapeutics

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$33Mraised across 1 round since 2024, from 1 source

Latest round
Series A, $33MMar 2024
Investors
3
See who backed them

The rounds

  1. Mar 2024

Founders and team

From Asgard Therapeutics's own website: 2 founders, 3 on the team.

Cristiana PiresPharmD PhD, Co-founder and CEO
Filipe PereiraPhD, Co-founder and Head of Innovation
  • Frank HenneckeHead of CMC
  • Jan VilladsenHead of Finance
  • Jonas JendiIndustrifonden, Board Member

AdvisersAurélien MarabelleBrian BrownIgnacio MeleroJoshua BrodyJulie M CherringtonUlrich Lauer

Everyone who backed them

Novo HoldingsVC firm1round
IndustrifondenVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Asgard Therapeutics

Who invested in Asgard Therapeutics?

Asgard Therapeutics's investors include Novo Holdings, Industrifonden and Boehringer Ingelheim Venture Fund.

How much has Asgard Therapeutics raised?

Asgard Therapeutics has raised $33M across 1 round since 2024.

When did Asgard Therapeutics last raise?

Asgard Therapeutics's most recent round was a Series A of $33M in Mar 2024.

What was Asgard Therapeutics's biggest round?

Its most recent round, $33M in Mar 2024, is also its largest on record.

Who backed Asgard Therapeutics first?

Asgard Therapeutics's first round on record, in Mar 2024, was backed by Novo Holdings, Industrifonden and Boehringer Ingelheim Venture Fund.

What stage is Asgard Therapeutics at?

Asgard Therapeutics's latest named round is a Series A, in Mar 2024.

Where is Asgard Therapeutics based?

Asgard Therapeutics is based in Sweden.

Companies like Asgard Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.